Join to View Full Profile
1930 E Thomas rdPhoenix, AZ 85016
Dr. Caskey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Michael Caskey, based in Phoenix, AZ, specializes in cardiovascular surgery and structural heart disease. He completed his medical education at the University of Texas Medical Branch School of Medicine in 1983 and underwent surgical residency at the University of Arizona College of Medicine-Phoenix until 1988, followed by a thoracic surgery residency at Rush University Medical Center from 1989 to 1991. Dr. Caskey has contributed to multiple publications, including research on transcatheter aortic valve replacement and transcatheter mitral valve replacement. His recognitions include being named among America's Top Doctors.
Education & Training
Rush University Medical CenterResidency, Thoracic Surgery - Independent, 1989 - 1991
University of Arizona College of Medicine-PhoenixResidency, Surgery, 1983 - 1988
University of Texas Medical Branch School of MedicineClass of 1983
Certifications & Licensure
OR State Medical License 2015 - Present
AZ State Medical License 1985 - 2026
TX State Medical License 1983 - 1999
IL State Medical License 1988 - 1993
OK State Medical License 1986 - 1986
American Board of Thoracic Surgery Thoracic and Cardiac Surgery
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2013-2014
- Top Doctors:Arizona State Castle Connolly, 2013
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Safety & Efficacy Study of the Medtronic CoreValve® System-Treatment of Symptomatic Severe Aortic Stenosis With Significant Comorbidities in Extreme Risk Subjects Who Need Aortic Valve Replacement
Publications & Presentations
PubMed
- 3 citationsFive-Year Follow-Up from the CoreValve Expanded Use Transcatheter Aortic Valve-in-Surgical Aortic Valve Study.Tanvir K Bajwa, Roger J Laham, Kamal Khabbaz, Harold L Dauerman, Ron Waksman
The American Journal of Cardiology. 2024-03-01 - 13 citationsFeasibility of Coronary Access Following Redo-TAVR for Evolut Failure: A Computed Tomography Simulation Study.Gilbert H L Tang, Julianne Spencer, Toby Rogers, Kendra J Grubb, Patrick Gleason
Circulation. Cardiovascular Interventions. 2023-11-01 - 10 citationsTranscarotid versus transaxillary access for transcatheter aortic valve replacement with a self-expanding valve: A propensity-matched analysis.Keith B Allen, Daniel Watson, Amit N Vora, Paul Mahoney, Adnan K Chhatriwalla
JTCVS Techniques. 2023-10-01
Press Mentions
Medtronic TAVR Systems Get FDA Approval for Expanded Redo TAVR IndicationAugust 29th, 2025- FDA Expands Evolut Indications to Include Redo TAVIAugust 29th, 2025
Apollo Plans a Heart Team to Help Patients BetterJune 7th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
